会員登録
ログイン
【4538】扶桑薬品工業
人工腎臓用透析剤・補液。
業績予想修正履歴
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.03 | 2024/02/13 | Q3予 | 53,300 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 1,300 | → | 0.0% | 0.0% |
| 2024.03 | 2023/11/10 | Q2予 | 53,300 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 1,300 | → | 0.0% | 0.0% |
| 2024.03 | 2023/08/09 | Q1予 | 53,300 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 1,300 | → | 0.0% | 0.0% |
| 2024.03 | 2023/05/10 | 当初予 | 53,300 | - | - | - | 2,000 | - | - | - | 2,000 | - | - | - | 1,300 | - | - | - |
| 2023.03 | 2023/05/10 | 実 | 51,015 | ↑ | +2.0% | +2.0% | 2,206 | ↑ | +16.1% | +37.9% | 2,215 | ↑ | +16.6% | +38.4% | 1,605 | ↑ | +14.6% | +45.9% |
| 2023.03 | 2023/02/10 | Q3予 | 50,000 | → | 0.0% | 0.0% | 1,900 | → | 0.0% | +18.8% | 1,900 | → | 0.0% | +18.8% | 1,400 | → | 0.0% | +27.3% |
| 2023.03 | 2022/11/09 | Q2予 | 50,000 | → | 0.0% | 0.0% | 1,900 | ↑ | +18.8% | +18.8% | 1,900 | ↑ | +18.8% | +18.8% | 1,400 | ↑ | +27.3% | +27.3% |
| 2023.03 | 2022/08/09 | Q1予 | 50,000 | → | 0.0% | 0.0% | 1,600 | → | 0.0% | 0.0% | 1,600 | → | 0.0% | 0.0% | 1,100 | → | 0.0% | 0.0% |
| 2023.03 | 2022/05/11 | 当初予 | 50,000 | - | - | - | 1,600 | - | - | - | 1,600 | - | - | - | 1,100 | - | - | - |
| 2022.03 | 2022/05/11 | 実 | 49,632 | ↑ | +0.9% | +2.3% | 1,924 | ↑ | +20.2% | +60.3% | 1,996 | ↑ | +24.8% | +81.5% | 1,483 | ↑ | +23.6% | +111.9% |
| 2022.03 | 2022/02/09 | Q3予 | 49,200 | → | 0.0% | +1.4% | 1,600 | → | 0.0% | +33.3% | 1,600 | → | 0.0% | +45.5% | 1,200 | → | 0.0% | +71.4% |
| 2022.03 | 2021/11/11 | Q2予 | 49,200 | ↑ | +1.4% | +1.4% | 1,600 | ↑ | +33.3% | +33.3% | 1,600 | ↑ | +45.5% | +45.5% | 1,200 | ↑ | +71.4% | +71.4% |
| 2022.03 | 2021/08/11 | Q1予 | 48,500 | → | 0.0% | 0.0% | 1,200 | → | 0.0% | 0.0% | 1,100 | → | 0.0% | 0.0% | 700 | → | 0.0% | 0.0% |
| 2022.03 | 2021/05/12 | 当初予 | 48,500 | - | - | - | 1,200 | - | - | - | 1,100 | - | - | - | 700 | - | - | - |
| 2021.03 | 2021/05/12 | 実 | 49,251 | ↑ | +0.1% | +0.9% | 2,351 | ↓ | -16.0% | +46.9% | 2,227 | ↓ | -14.3% | +48.5% | 1,607 | ↓ | -15.4% | +46.1% |
| 2021.03 | 2021/02/09 | Q3予 | 49,200 | → | 0.0% | +0.8% | 2,800 | → | 0.0% | +75.0% | 2,600 | → | 0.0% | +73.3% | 1,900 | → | 0.0% | +72.7% |
| 2021.03 | 2020/11/10 | Q2予 | 49,200 | ↑ | +0.8% | +0.8% | 2,800 | ↑ | +75.0% | +75.0% | 2,600 | ↑ | +73.3% | +73.3% | 1,900 | ↑ | +72.7% | +72.7% |
| 2021.03 | 2020/08/11 | Q1予 | 48,800 | - | - | - | 1,600 | - | - | - | 1,500 | - | - | - | 1,100 | - | - | - |
| 2020.03 | 2020/05/12 | 修正予 | 48,800 | ↑ | +4.1% | +5.6% | 1,600 | ↑ | +146.2% | +146.2% | 1,500 | ↑ | +41.5% | +150.0% | 1,100 | ↑ | +57.1% | +175.0% |
| 2020.03 | 2020/05/07 | 修正予 | 46,900 | ↑ | +1.5% | +1.5% | - | - | - | - | 1,060 | ↑ | +76.7% | +76.7% | 700 | ↑ | +75.0% | +75.0% |
| 2020.03 | 2020/02/10 | Q3予 | 46,200 | → | 0.0% | 0.0% | 650 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% | 400 | → | 0.0% | 0.0% |
| 2020.03 | 2019/11/08 | Q2予 | 46,200 | → | 0.0% | 0.0% | 650 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% | 400 | → | 0.0% | 0.0% |
| 2020.03 | 2019/08/08 | Q1予 | 46,200 | → | 0.0% | 0.0% | 650 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% | 400 | → | 0.0% | 0.0% |
| 2020.03 | 2019/05/10 | 当初予 | 46,200 | - | - | - | 650 | - | - | - | 600 | - | - | - | 400 | - | - | - |
| 2019.03 | 2019/05/10 | 実 | 46,074 | ↓ | -0.3% | -0.3% | 1,261 | ↑ | +26.1% | +26.1% | 1,279 | ↑ | +42.1% | +42.1% | 894 | ↑ | +49.0% | +49.0% |
| 2019.03 | 2019/02/08 | Q3予 | 46,200 | → | 0.0% | 0.0% | 1,000 | → | 0.0% | 0.0% | 900 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% |
| 2019.03 | 2018/11/07 | Q2予 | 46,200 | → | 0.0% | 0.0% | 1,000 | → | 0.0% | 0.0% | 900 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% |
| 2019.03 | 2018/08/08 | Q1予 | 46,200 | → | 0.0% | 0.0% | 1,000 | - | - | - | 900 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% |
| 2019.03 | 2018/05/10 | 当初予 | 46,200 | - | - | - | - | - | - | - | 900 | - | - | - | 600 | - | - | - |
| 2018.03 | 2018/05/10 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2018.03 | 2018/02/08 | Q3予 | 47,300 | → | 0.0% | 0.0% | 800 | → | 0.0% | 0.0% | 800 | → | 0.0% | 0.0% | 1,000 | → | 0.0% | +66.7% |
| 2018.03 | 2017/11/08 | Q2予 | 47,300 | → | 0.0% | 0.0% | 800 | → | 0.0% | 0.0% | 800 | → | 0.0% | 0.0% | 1,000 | ↑ | +66.7% | +66.7% |
| 2018.03 | 2017/08/08 | Q1予 | 47,300 | → | 0.0% | 0.0% | 800 | → | 0.0% | 0.0% | 800 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% |
| 2018.03 | 2017/05/11 | 当初予 | 47,300 | - | - | - | 800 | - | - | - | 800 | - | - | - | 600 | - | - | - |
| 2017.03 | 2017/05/11 | 実 | 46,782 | ↓ | -0.5% | -0.5% | 656 | ↓ | -27.1% | -53.1% | 642 | ↓ | -24.5% | -46.5% | 861 | ↓ | -4.3% | +7.6% |
| 2017.03 | 2017/02/08 | Q3予 | 47,000 | → | 0.0% | 0.0% | 900 | ↓ | -35.7% | -35.7% | 850 | ↓ | -29.2% | -29.2% | 900 | ↑ | +12.5% | +12.5% |
| 2017.03 | 2016/05/10 | 当初予 | 47,000 | - | - | - | 1,400 | - | - | - | 1,200 | - | - | - | 800 | - | - | - |
| 2016.03 | 2016/05/10 | 実 | 45,752 | ↓ | -0.5% | -0.5% | 296 | ↓ | -50.7% | -50.7% | 172 | ↓ | -57.0% | -57.0% | 10 | ↓ | -96.7% | -96.7% |
| 2016.03 | 2016/02/05 | Q3予 | 46,000 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% | 400 | → | 0.0% | 0.0% | 300 | → | 0.0% | 0.0% |
| 2016.03 | 2015/11/06 | Q2予 | 46,000 | → | 0.0% | 0.0% | 600 | → | 0.0% | 0.0% | 400 | → | 0.0% | 0.0% | 300 | → | 0.0% | 0.0% |
| 2016.03 | 2015/08/07 | Q1予 | 46,000 | → | 0.0% | 0.0% | 600 | - | - | - | 400 | → | 0.0% | 0.0% | 300 | → | 0.0% | 0.0% |
| 2016.03 | 2015/05/08 | 当初予 | 46,000 | - | - | - | - | - | - | - | 400 | - | - | - | 300 | - | - | - |
| 2015.03 | 2015/05/08 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2015.03 | 2015/02/06 | Q3予 | 47,600 | → | 0.0% | -2.5% | 600 | → | 0.0% | -60.0% | 500 | → | 0.0% | -64.3% | 350 | → | 0.0% | -61.1% |
| 2015.03 | 2014/11/07 | Q2予 | 47,600 | ↓ | -2.5% | -2.5% | 600 | ↓ | -60.0% | -60.0% | 500 | ↓ | -64.3% | -64.3% | 350 | ↓ | -61.1% | -61.1% |
| 2015.03 | 2014/08/08 | Q1予 | 48,800 | → | 0.0% | 0.0% | - | - | - | - | 1,400 | → | 0.0% | 0.0% | 900 | → | 0.0% | 0.0% |
| 2015.03 | 2014/05/09 | 当初予 | 48,800 | - | - | - | 1,500 | - | - | - | 1,400 | - | - | - | 900 | - | - | - |
| 2014.03 | 2014/05/09 | 実 | 49,098 | - | - | - | 2,797 | - | - | - | 2,741 | - | - | - | 1,979 | - | - | - |
